A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer
and of evaluating the functions of such mutations in combination. This method may become a foundation for the in vitro and in vivo assessment of variants of cancer-related genes and help customize cancer therapy for individual patients.
